CTT Pharma gets U.S. patent for nicotine, vitamin, caffeine delivery tech

CTT PHARMACEUTICAL HOLDINGS, INC.

USPTO approved continuation-in-part patent for micelle delivery technology, effective Aug 11, 2026.
Patent covers nicotine, vitamins, and caffeine; enables dissolvable strips, gum, pouches, lozenges, and dissolving tablets.
Company states it will continue strengthening its patent portfolio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.